# Management of Hip Fractures in Older Adults: Comprehensive Study Guide This study guide is based on the 2021 Evidence-Based Clinical Practice Guideline developed by the American Academy of Orthopaedic Surgeons (AAOS). It focuses on the surgical and perioperative management of hip fractures in adults aged 55 and older. --- ## Part 1: Key Concepts and Clinical Recommendations The following table summarizes the primary recommendations for the management of hip fractures, categorized by the strength of the recommendation and the quality of the supporting evidence. ### Surgical and Perioperative Management | Category | Recommendation | Strength | Evidence Quality | | :--- | :--- | :--- | :--- | | **Preoperative Traction** | Should **not** be routinely used. Alternatives like positioning with pillows are feasible and acceptable. | Strong | High | | **Surgical Timing** | Surgery within **24–48 hours** of admission is associated with better outcomes (pain, complications, and mortality). | Moderate | Low (Upgraded) | | **VTE Prophylaxis** | Prophylaxis (mechanical or pharmacological) **should be used** to prevent DVT and PE. | Strong | Moderate (Upgraded) | | **Anesthesia** | Both **spinal and general anesthesia** are appropriate; evidence does not show one is superior for mortality or length of stay. | Strong | High | | **Femoral Stems** | Use of **cemented femoral stems** is recommended for arthroplasty to reduce periprosthetic fracture risk. | Strong | High | | **Transfusion** | A threshold of **no higher than 8g/dl** is suggested for asymptomatic postoperative patients. | Moderate | Moderate | | **Analgesia** | **Multimodal analgesia**, including preoperative nerve blocks, is recommended for pain management. | Strong | High | | **Blood Loss** | **Tranexamic Acid (TXA)** should be administered to reduce blood loss and the need for transfusions. | Strong | High | | **Care Delivery** | **Interdisciplinary care programs** should be utilized to decrease complications and improve outcomes. | Strong | High | ### Device and Procedure Selection | Fracture Type | Recommended Treatment | Strength | | :--- | :--- | :--- | | **Unstable Femoral Neck** | **Arthroplasty** is recommended over internal fixation. | Strong | | **Unstable Femoral Neck** | **Total Hip Arthroplasty (THA)** may offer functional benefits over hemiarthroplasty in selected patients, despite higher complication risks. | Moderate (Downgraded) | | **Unstable Femoral Neck** | Unipolar and bipolar hemiarthroplasty are **equally beneficial**. | Moderate | | **Stable Intertrochanteric** | Either a **sliding hip screw** or a **cephalomedullary device** is recommended. | Strong | | **Subtrochanteric/Reverse Obliquity** | A **cephalomedullary device** is recommended. | Strong | | **Unstable Intertrochanteric** | A **cephalomedullary device** is recommended. | Strong | --- ## Part 2: Short-Answer Practice Questions **1. Why is preoperative traction generally discouraged for hip fracture patients?** Based on high-quality evidence, preoperative traction does not improve pain scores or reduce complications compared to simple positioning (e.g., using pillows). Furthermore, it may increase complications like pressure ulcers and urinary tract infections, and could potentially trigger delirium in patients with dementia. **2. What are the specific timing goals for hip fracture surgery and why?** Surgery should ideally occur within 24 to 48 hours of admission. This timeframe is associated with improved outcomes regarding pain, length of hospital stay, and a general reduction in mortality risk. **3. When treating unstable femoral neck fractures, what are the trade-offs between Total Hip Arthroplasty (THA) and hemiarthroplasty?** THA may provide a small functional benefit to patients compared to hemiarthroplasty. However, THA is associated with a higher risk of complications, such as dislocation and instability, and generally incurs higher implant costs and professional fees. **4. What is the recommended blood transfusion threshold for asymptomatic postoperative patients?** The guideline suggests a threshold of no higher than 8g/dl for patients who are not showing symptoms of anemia. **5. What is the primary benefit of using cemented femoral stems in hip arthroplasty for these patients?** The primary benefit is a lower risk of postoperative periprosthetic fractures and improved short-term patient-reported outcomes, though the procedure may involve slightly longer surgical time and higher blood loss. **6. Does the current evidence favor a specific surgical approach for hip arthroplasty?** No. Evidence does not show a favored surgical approach (e.g., anterior, lateral, or posterior). While some approaches may reduce short-term pain or dislocation rates in specific studies, no approach has demonstrated overall superiority in long-term functional outcomes. --- ## Part 3: Essay Prompts for Deeper Exploration **1. The Role of Interdisciplinary Care in Geriatric Hip Fracture Management** Discuss the importance of interdisciplinary care programs in treating older adults with hip fractures. How do these programs address the complexities of patient comorbidities, and what specific outcomes (e.g., mortality, mobility, and complications) are they intended to improve? **2. Balancing Risk and Benefit in Surgical Device Selection** Analyze the decision-making process for choosing between a sliding hip screw and a cephalomedullary device in intertrochanteric fractures. Contrast the requirements for stable versus unstable or reverse-obliquity fractures and explain how fracture morphology dictates the optimal mechanical intervention. **3. Thromboembolism Prophylaxis: Ethical and Clinical Considerations** The AAOS upgraded the recommendation for VTE prophylaxis to "Strong" despite "Moderate" evidence quality. Evaluate the clinical rationale for this upgrade, focusing on the risk-to-benefit ratio of pharmacological and mechanical prophylaxis in a vulnerable, aging population. --- ## Part 4: Glossary of Important Terms * **Arthroplasty:** A surgical procedure to restore the function of a joint, which may involve replacing the joint with an artificial prosthesis (e.g., total hip arthroplasty or hemiarthroplasty). * **Cephalomedullary Device:** An intramedullary nail system used for the fixation of fractures in the trochanteric region, extending from the femoral head into the medullary canal. * **DVT (Deep Vein Thrombosis):** A blood clot that forms in a deep vein, typically in the legs; a significant risk factor following hip surgery. * **Evidence-to-Decision (EtD) Framework:** A systematic process used by the AAOS to incorporate factors such as benefits/harms, patient values, and resource use to determine the final strength of a recommendation. * **Hemiarthroplasty:** A surgical procedure that replaces only one half of the hip joint (the femoral head) with a prosthesis, leaving the natural socket (acetabulum) intact. * **Intertrochanteric Fracture:** A fracture occurring between the greater and lesser trochanters of the femur. * **Multimodal Analgesia:** A pain management strategy that uses multiple classes of medications or techniques (e.g., nerve blocks combined with non-opioid medications) to improve pain relief and reduce opioid consumption. * **PICO Questions:** A standard format for clinical research questions, standing for Population, Intervention, Comparison, and Outcome. * **Reverse Obliquity Fracture:** A specific fracture pattern of the proximal femur where the fracture line runs from the medial cortex distally to the lateral cortex proximally, often requiring a cephalomedullary device for stability. * **Tranexamic Acid (TXA):** An antifibrinolytic medication administered to reduce surgical blood loss and the need for postoperative blood transfusions. * **VTE (Venous Thromboembolism):** A category of conditions that includes both Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE).